Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Shenzhen Institute of Pediatrics, |
RCV000469192 | SCV000538201 | pathogenic | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2015-10-30 | criteria provided, single submitter | clinical testing | the genetype:[c.211C>T(p.Gln71*)]+[c.680G>A(p.Arg227Gln)] |
Invitae | RCV000469192 | SCV003524206 | pathogenic | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2023-03-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 403724). This premature translational stop signal has been observed in individuals with steroid-5 alpha-reductase deficiency (PMID: 20736251, 22453073). This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Gln71*) in the SRD5A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SRD5A2 are known to be pathogenic (PMID: 1406794, 1944596). |